Literature DB >> 9950293

Molecular mechanisms of the adsorption of a model protein (human serum albumin) on poly(methylidene malonate 2.1.2) nanoparticles.

Y Bousquet1, P J Swart, N Schmitt-Colin, F Velge-Roussel, M E Kuipers, D K Meijer, N Bru, J Hoebeke, P Breton.   

Abstract

PURPOSE: To understand the molecular mechanisms involved in protein-methylidene malonate 2.1.2 polymer interactions.
METHODS: To assess the importance of electrostatic forces in polymer-protein interactions use was made of HSA and its derivatives, which were anionized by succinylation and aconitylation. Surface plasmon resonance measurements, using the three HSA molecules as immobilized ligands and polymer nanoparticles as analytes in the liquid phase, allowed the determination of initial kinetic constants and affinity constants at equilibrium at two different temperatures.
RESULTS: Saturation of binding for the three proteins occurred at approximately 900 protein molecules/nanoparticle. The apparent affinity decreased with increasing electronegativity of the proteins. Surface plasmon resonance measurement of proteins, covalently linked to the chip matrix, showed a high affinity for the nanoparticles (K(A) approximately 10(10) M(-1) and confirmed the moderate decrease of affinity with increasing electronegativity of the modified albumins. Measurements at 25 and 37 degrees C showed no significant increase in the albumin-nanoparticle interactions. Dissociation of the proteins from the nanoparticles could only be realized with chaotropic salt solutions.
CONCLUSIONS: These results suggest the molecular forces initiating the protein-nanoparticle interactions are mainly of electrostatic nature followed by stabilization by hydrophobic forces. The high affinity confirms the nanoparticles as excellent carriers for protein delivery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950293     DOI: 10.1023/a:1018843401077

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors.

Authors:  B Johnsson; S Löfås; G Lindquist
Journal:  Anal Biochem       Date:  1991-11-01       Impact factor: 3.365

Review 2.  Biospecific interaction analysis using biosensor technology.

Authors:  M Malmqvist
Journal:  Nature       Date:  1993-01-14       Impact factor: 49.962

3.  Immunochemical characterization of antibody-coated nanoparticles.

Authors:  F Velge-Roussel; P Breton; X Guillon; F Lescure; N Bru; D Bout; J Hoebeke
Journal:  Experientia       Date:  1996-08-15

4.  Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.

Authors:  R W Jansen; G Molema; R Pauwels; D Schols; E De Clercq; D K Meijer
Journal:  Mol Pharmacol       Date:  1991-06       Impact factor: 4.436

5.  The interaction of amino acids with ophthaldialdehyde: a kinetic study and spectrophotometric assay of the reaction product.

Authors:  V J Svedas; I J Galaev; I L Borisov; I V Berezin
Journal:  Anal Biochem       Date:  1980-01-01       Impact factor: 3.365

6.  Thermodynamics of protein association reactions: forces contributing to stability.

Authors:  P D Ross; S Subramanian
Journal:  Biochemistry       Date:  1981-05-26       Impact factor: 3.162

7.  Preparation and characterization of novel poly(methylidene malonate 2.1.2.)-made nanoparticles.

Authors:  F Lescure; C Seguin; P Breton; P Bourrinet; D Roy; P Couvreur
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

8.  Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120.

Authors:  M E Kuipers; J G Huisman; P J Swart; M P de Béthune; R Pauwels; H Schuitemaker; E De Clercq; D K Meijer
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-04-15

9.  Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.

Authors:  R W Jansen; D Schols; R Pauwels; E De Clercq; D K Meijer
Journal:  Mol Pharmacol       Date:  1993-11       Impact factor: 4.436

  9 in total
  5 in total

1.  Microimmunoassay using a protein chip: optimizing conditions for protein immobilization.

Authors:  Seung-Yong Seong
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 2.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Authors:  Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil
Journal:  Adv Drug Deliv Rev       Date:  2009-04-17       Impact factor: 15.470

3.  Rapid and simultaneous detection of human hepatitis B virus and hepatitis C virus antibodies based on a protein chip assay using nano-gold immunological amplification and silver staining method.

Authors:  Lianlian Duan; Yefu Wang; Shawn Shun-cheng Li; Zhixiang Wan; Jianxin Zhai
Journal:  BMC Infect Dis       Date:  2005-07-06       Impact factor: 3.090

4.  The fate of a designed protein corona on nanoparticles in vitro and in vivo.

Authors:  Denise Bargheer; Julius Nielsen; Gabriella Gébel; Markus Heine; Sunhild C Salmen; Roland Stauber; Horst Weller; Joerg Heeren; Peter Nielsen
Journal:  Beilstein J Nanotechnol       Date:  2015-01-06       Impact factor: 3.649

Review 5.  Cancer Nano-Immunotherapy from the Injection to the Target: The Role of Protein Corona.

Authors:  Idoia Mikelez-Alonso; Antonio Aires; Aitziber L Cortajarena
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.